| Jennifer-nicole Lee Wood, OTR/L | |
|
2703 Legends Pkwy, Prattville, AL 36066-7755 | |
| (334) 380-4930 | |
| (205) 803-6605 |
| Full Name | Jennifer-nicole Lee Wood |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 9 Years |
| Location | 2703 Legends Pkwy, Prattville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164872073 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 4244 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agilitas Usa Inc | 3375454648 | 634 |
News Archive
In a study that analyzed relationships between air quality and unemployment levels, a Tufts University researcher has developed a new statistical model that retrospectively estimates air pollution exposure for previous time periods where such information is not available.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.
› Verified 4 days ago
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20120523000672 |
News Archive
In a study that analyzed relationships between air quality and unemployment levels, a Tufts University researcher has developed a new statistical model that retrospectively estimates air pollution exposure for previous time periods where such information is not available.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.
› Verified 4 days ago
| Provider Name | Drayer Physical Therapy-alabama, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1023440583 PECOS PAC ID: 5395970560 Enrollment ID: O20150417000513 |
News Archive
In a study that analyzed relationships between air quality and unemployment levels, a Tufts University researcher has developed a new statistical model that retrospectively estimates air pollution exposure for previous time periods where such information is not available.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer-nicole Lee Wood, OTR/L 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 238-7217 | Jennifer-nicole Lee Wood, OTR/L 2703 Legends Pkwy, Prattville, AL 36066-7755 Ph: (334) 380-4930 |
News Archive
In a study that analyzed relationships between air quality and unemployment levels, a Tufts University researcher has developed a new statistical model that retrospectively estimates air pollution exposure for previous time periods where such information is not available.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.
› Verified 4 days ago
Mrs. Kristin Taylor, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 635 Mcqueen Smith Road, Suite D, Prattville, AL 36066 Phone: 334-358-6501 | |
Pptc, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 115 N Memorial Dr, Prattville, AL 36067 Phone: 256-609-6946 | |
Cimone Davis, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 660 Mcqueen Smith Rd N Ste H, Prattville, AL 36066 Phone: 334-350-3362 | |
Shelby Ware, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2188 Addison Way, Prattville, AL 36066 Phone: 205-541-9761 | |
Laura Killough, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 635 Mcqueen Smith Rd N Ste D, Prattville, AL 36066 Phone: 334-365-8063 | |
Janea Christine Carter, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 564 N Memorial Dr, Prattville, AL 36067 Phone: 334-491-0066 Fax: 334-491-0067 |